BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03516279-completion@plaintrial.com
DTSTAMP:20261027T155150Z
DTSTART;VALUE=DATE:20310831
SUMMARY:Pembrolizumab and Dasatinib\, Imatinib Mesylate\, or Nilotinib in T
 reating Patients With Chronic Myeloid Leukemia and Persistently Detectable
  Minimal Residual Disease — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03516279
URL:https://plaintrial.com/trial/NCT03516279
END:VEVENT
END:VCALENDAR